FMP
Myrexis, Inc.
MYRX
PNK
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
0.007 USD
0 (0%)
Valuation Date:
Mar 19, 2025 4:00 PM
Share Price on Valuation Date
$0.01
Stock Beta
1.538
Shares Outstanding
34479000